The Annual Growth Survey 2016 highlighted that investing in R&I at national level is critical for growth and that therefore Member States should continue to prioritise public investments in R&I, ensuring their efficiency and leverage with regard to business investment. Member States need to keep up the pace of reforms to ensure an investment-friendly environment. See more information about the European Semester.
The European Semester supports Member States' structural reforms in different policy areas to promote jobs, growth and investment. Research and innovation play a key role in this context. That is why the Commission gives recommendations to and closely work with the Member States to increase the performance of their national R&I systems.
Have a look and see how the country is performing.
R&D intensity has increased significantly in recent years, reaching 1.95 % of GDP in 2015, nearly at par with the EU average of 2 %. The national target for public R&D expenditure (1 % of GDP in 2020) will be attained (Office of the Government of the Czech Republic, 2015a).
The strong increase in R&D intensity since 2005 is not being matched by corresponding improvements in the quality of outcomes. While progress has been made, the Czech Republic still fares significantly below the average EU performance in terms of openness and excellence of its research system and intellectual assets according to the 2016 European Innovation Scoreboard.
The Czech authorities have set out a list of priorities for the R&D sector, in line with the recently-adopted European Research Area Roadmap (2016-2020). Proposed reforms to the governance of the R&D system are being pursued. In September 2016 the updated National Research and Innovation Strategy for Smart Specialisation was approved by the Commission. Furthermore, a number of operational programmes are being also put into place to support R&D, innovation and competitiveness.
The new evaluation methodology (Metodika 17+), which intends to strengthen the steering and structure of responsibilities related to the evaluation and allocation of research funding was approved by the government in February 2017.